None listed
Conditions
Interventions
Intervention 1: Control group: Given that the age variable is an important confounding factor, in this study we will have 2 control groups as follows: Control group with an age range of 30 to 45 years
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Having dark circles and wrinkles on the face Complete patient consent to participate in the project Age 30 years and above and less than 60 years
Exclusion criteria
Exclusion criteria: Active wound or infection at the treatment site Receiving chemotherapy within the last 5 years Pregnancy or breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| WSRS scale (Wrinkle Severity Rating Scale). Timepoint: Before treatment, 1, 3 and 6 months after treatment. Method of measurement: Questionnaire (SERVQUAL).;FVLS Scale (Facial Volume Loss Score). Timepoint: Before treatment, 1, 3 and 6 months after treatment. Method of measurement: Questionnaire (SERVQUAL).;Body mass index. Timepoint: Before treatment, 1, 3 and 6 months after treatment. Method of measurement: Questionnaire (SERVQUAL). | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction. Timepoint: Before treatment, 1, 3 and 6 months after treatment. Method of measurement: Questionnaire (SERVQUAL).;Physician satisfaction. Timepoint: Before treatment, 1, 3 and 6 months after treatment. Method of measurement: Questionnaire (SERVQUAL). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. AfsanehSadeghzadeh Bazargan
Iran University of Medical Sciences
Outcome results
None listed